
Novo Nordisk has issued a voluntary recall of 1,468 samles containing insulin products which were stored at the wrong temperatures during the raging winter storms in Texas in February, according to a press release from the firm.
The power outages resulting from the storm meant that the products including Levemir, Tresiba, Fiasp, Novolog and Xultophy could not be stored in proper temperature conditions.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app